English
Specials
    Premium
    My Alerts
    MoneycontrolGo PRO @₹99
    Moneycontrol PRO
    Check Credit Score
    Check Credit Score
    chakra

    Countdown to Lok Sabha Elections 2024

    voteFULL COVERAGE
    HomeNewsBusinessAnnouncements

    Zydus Cadila receives final approval from USFDA for Tizanidine Hydrochloride capsules

    Cadila Healthcare has received final approval from the USFDA to market Tizanidine Hydrochloride capsules, USP in strength of 2 mg, 4m g and 6 mg.

    March 08, 2017 / 10:56 AM IST
     
     
    live
    • bselive
    • nselive
    Volume
    Todays L/H
    More

    We enclose herewith a copy of press release dated March 8, 2017, titled Zydus Cadila receives final approval from the USFDA for Tizanidine Hydrochloride Capsules.Source : BSE

    Read all announcements in Cadila Health

    Read More Read More

    Tags: #Announcements
    first published: Mar 8, 2017 10:56 am

    Discover the latest business news, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347